Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).

Farooq S, Nazar Z, Irfan M, Akhter J, Gul E, Irfan U, Naeem F.

Br J Psychiatry. 2011 Dec;199(6):467-72. doi: 10.1192/bjp.bp.110.085340.

2.

[Therapeutic alliance, a stake in schizophrenia].

Charpentier A, Goudemand M, Thomas P.

Encephale. 2009 Feb;35(1):80-9. doi: 10.1016/j.encep.2007.12.009. Epub 2008 May 19. Review. French.

PMID:
19250998
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
5.

Improving treatment adherence in your patients with schizophrenia: the STAY initiative.

Cañas F, Alptekin K, Azorin JM, Dubois V, Emsley R, García AG, Gorwood P, Haddad PM, Naber D, Olivares JM, Papageorgiou G, Roca M.

Clin Drug Investig. 2013 Feb;33(2):97-107. doi: 10.1007/s40261-012-0047-8. Review.

PMID:
23288695
6.

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.

Barkhof E, Meijer CJ, de Sonneville LM, Linszen DH, de Haan L.

Eur Psychiatry. 2012 Jan;27(1):9-18. doi: 10.1016/j.eurpsy.2011.02.005. Epub 2011 May 10. Review.

7.

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders.

Sendt KV, Tracy DK, Bhattacharyya S.

Psychiatry Res. 2015 Jan 30;225(1-2):14-30. doi: 10.1016/j.psychres.2014.11.002. Epub 2014 Nov 12. Review.

PMID:
25466227
Items per page

Supplemental Content

Write to the Help Desk